Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 4;24(1):25.
doi: 10.1186/s12913-023-10433-7.

Cost and availability of selected medicines after implementation of increased import verification fees

Helen Byomire Ndagije  1 , Diana Nakitto Kesi  2 , Kalidi Rajab  3 , Solomon Onen  1 , Allan Serwanga  1 , Leonard Manirakiza  4 , Sheila Ampaire  1 , Joseph Mutasaaga  1 , Denis Mwesigwa  1 , David Nahamya  1
Affiliations

Cost and availability of selected medicines after implementation of increased import verification fees

Helen Byomire Ndagije et al. BMC Health Serv Res. .

Abstract

Background: Uganda imports approximately 90% of its medicines, with about 60% being distributed by the private sector. To discourage importation and promote local production of 37 selected locally manufactured medicines, the Ugandan government through the Ministry of Health in 2017 increased the import verification fees from 2 to 12%. The increase in verification fees ultimately affects cost and availability of these medicines. This study aimed to assess the cost and availability of the selected essential medicines after the 12% increase in verification fees in Uganda.

Methods: A cross sectional study among 328 wholesale and retail pharmacies and seven key informant interviews was conducted using a pretested data collection checklist and in-depth interview guide from February to September 2021 in Uganda. Data on the availability and prices of the medicines before (2017) and after (2020) the increase in verification fees was collected. Paired sample T-Test was used to test if there is a significant difference in prices before and after the 12% increase in verification fees.

Results: Mean availability of imported medicines was higher (54.8%, CI: 49.3-60.4) than the locally produced medicines (37.1%, CI: 31.9-42.7) except for locally manufactured parenteral preparations (54.6.%, CI: 49.1-60.1). Availability of locally produced medicines was mainly low (45%) while the imported medicines were fairly high (74%). Most commonly available locally manufactured medicines were Surgical spirit (89.9%), ORS (86%), Dextrose 5% solution (74.4%), Paracetamol 500 mg Tablets (73.8%) and Sodium Chloride 0.9% solution (72.9%). Most commonly available imported medicines were; Omeprazole 20 mg (94.2%), Amoxicillin Trihydrate 125 mg/5 ml (92.4%), Ciprofloxacin 500 mg (91.4%), Paracetamol Suspension 120 mg/5 ml (91.5%) and Metronidazole 200 mg Tablets (88.1%). Increase in lowest-priced local and imported medicines was significant for 10 (23.8%) and 7 (15.9%) of the medicines respectively. The median prices of imported medicines were generally higher than locally produced medicines. The median unit prices of 12 (28.6%) locally produced medicines and 20 (47.6%) imported medicines were higher than the international median unit prices.

Conclusions: The overall availability of imported medicines was still higher than the local medicines. The median prices of local and imported medicines generally increased or remained the same after the introduction of import verification fees. There is a need for price controls and transparency in the private sector.

Keywords: Availability of medicines; Cost of medicines; Import verification fees; Imported products; Local products.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. UNIDO. SUPPORTING PHARMACEUTICAL PRODUCTION IN AFRICA, Global UNIDO, Project. Strengthening the local production of essential medicines in developing countries through advisory and capacity building support. United National Industrial Development Organization.; 2016, https://www.unido.org/sites/default/files/2015-05/PRINT_Pharma_Brochure_....
    1. Dong J, Mirza Z. Supporting the production of pharmaceuticals in Africa. Bull World Health Organ. 2016;94(1):71–2. doi: 10.2471/BLT.15.163782. - DOI - PMC - PubMed
    1. Uganda-Country-Commercial-Guide. Uganda Pharmaceuticals Uganda2017 [Available from: https://www.export.gov/article?id=Uganda-Pharmaceuticals.
    1. Baldeh AO, Millard C, Pollock AM, Brhlikova P. Bridging the gap? Local production of medicines on the national essential medicine lists of Kenya, Tanzania and Uganda. J Pharm Policy Pract. 2023;16(1):18. doi: 10.1186/s40545-022-00497-x. - DOI - PMC - PubMed
    1. Ministry of Trade., Industry and Cooperatives, Buy Uganda Build Uganda Policy,2014. https://www.bubuexpo.com/wp-content/uploads/2019/BUBU%20Policy.pdf.

LinkOut - more resources